AbbVie Inc (ABBV)
162.73
-1.06
(-0.65%)
USD |
NYSE |
May 06, 16:00
162.27
-0.46
(-0.28%)
After-Hours: 20:00
AbbVie Market Cap: 287.36B for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 287.36B |
| May 03, 2024 | 289.23B |
| May 02, 2024 | 283.97B |
| May 01, 2024 | 285.58B |
| April 30, 2024 | 287.20B |
| April 29, 2024 | 285.22B |
| April 26, 2024 | 281.87B |
| April 25, 2024 | 295.41B |
| April 24, 2024 | 296.29B |
| April 23, 2024 | 299.36B |
| April 22, 2024 | 296.45B |
| April 19, 2024 | 293.83B |
| April 18, 2024 | 290.74B |
| April 17, 2024 | 290.02B |
| April 16, 2024 | 287.00B |
| April 15, 2024 | 285.46B |
| April 12, 2024 | 286.54B |
| April 11, 2024 | 295.79B |
| April 10, 2024 | 298.46B |
| April 09, 2024 | 300.42B |
| April 08, 2024 | 299.82B |
| April 05, 2024 | 300.17B |
| April 04, 2024 | 296.46B |
| April 03, 2024 | 313.12B |
| April 02, 2024 | 319.05B |
| Date | Value |
|---|---|
| April 01, 2024 | 319.17B |
| March 28, 2024 | 322.43B |
| March 27, 2024 | 319.34B |
| March 26, 2024 | 317.28B |
| March 25, 2024 | 316.11B |
| March 22, 2024 | 315.97B |
| March 21, 2024 | 314.29B |
| March 20, 2024 | 312.11B |
| March 19, 2024 | 318.11B |
| March 18, 2024 | 316.04B |
| March 15, 2024 | 314.96B |
| March 14, 2024 | 320.84B |
| March 13, 2024 | 318.47B |
| March 12, 2024 | 320.35B |
| March 11, 2024 | 318.06B |
| March 08, 2024 | 316.68B |
| March 07, 2024 | 319.73B |
| March 06, 2024 | 320.59B |
| March 05, 2024 | 317.23B |
| March 04, 2024 | 313.49B |
| March 01, 2024 | 316.04B |
| February 29, 2024 | 310.99B |
| February 28, 2024 | 314.43B |
| February 27, 2024 | 316.18B |
| February 26, 2024 | 315.86B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
93.11B
Minimum
Aug 15 2019
322.43B
Maximum
Mar 28 2024
210.54B
Average
207.70B
Median
Jul 22 2021
Market Cap Benchmarks
| Amgen Inc | 160.69B |
| Johnson & Johnson | 357.58B |
| Eli Lilly and Co | 728.66B |
| Merck & Co Inc | 323.11B |
| Pfizer Inc | 159.46B |
Market Cap Related Metrics
| PE Ratio | 48.29 |
| PS Ratio | 5.303 |
| Price to Book Value | 35.89 |
| Price to Free Cash Flow | 13.18 |
| Price | 162.73 |
| Earnings Yield | 2.07% |
| Operating PE Ratio | 21.24 |
| Normalized PE Ratio | 43.31 |